Companies: 10,795·Total market cap: $144.5T
ResMed Inc.

ResMed Inc.

RMDNYSEHealthcare● Active
$193.14
$-2.90(-1.48%)
Market Cap$28.0B
P/E Ratio
52W High$293.81
52W Low$180.27

ResMed Inc. (RMD) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

RMD · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $1.40B for FY2025 (fiscal year ending 2025-06-30), up 37.2% year-over-year. Net profit margin was 27.2%. Based on available data, ResMed Inc. has been profitable since at least 2011.

FY2025 Net Income$1.40B▲ +37.2% YoY
Trailing 12M (TTM)$1.52Btrailing 4 quarters sum
Net Profit Margin27.2%$1.40B ÷ $5.15B
YoY Change+37.2%
5-Year CAGR+17.6%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · RMD net income history · RMD profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$1.40B▲ +37.2%27.2%
FY2024$1.02B▲ +13.7%21.8%
FY2023$897.6M▲ +15.2%21.3%
FY2022$779.4M▲ +64.3%21.8%
FY2021$474.5M▼ 23.7%14.8%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
ResMed Inc.
ResMed Inc.YOU
RMD
$1.40B+37.2%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

ResMed Inc. (RMD) reported net income of $1.40B for FY2025 (fiscal year ending 2025-06-30), up 37.2% year-over-year. The net profit margin was 27.2% — meaning the company kept $0.27 of every dollar of revenue as profit.

Based on available data, ResMed Inc. has been profitable since at least 2011. Net income reached a peak of $1.40B in FY2025. Data available for 15 fiscal years.

ResMed Inc.'s net profit margin was 27.2% for FY2025, based on the latest annual results.

Investors sometimes search for "ResMed Inc. net worth" — the company's market capitalization is a separate figure from RMD net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

RMD net income · 5 questions

ResMed Inc. is profitable. The company reported net income of $1.40B for FY2025, a net profit margin of 27.2%. Net income was up 37.2% year-over-year. Based on available data, ResMed Inc. has been profitable since at least 2011.

is RMD profitabledoes RMD make a profitRMD profitabilityRMD profitable company

Source: FMP /income-statement · GAAP · ResMed Inc. · ResMed Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026